细胞淋巴瘤-话题@MedSci

#细胞淋巴瘤#

385篇内容 | 5357人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1702488, encodeId=bcf91e02488e4, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=华氏巨球蛋白血症/淋巴浆细胞淋巴瘤 NCCN 新版指南（2018.V1）解读, objectType=article, longId=137349, objectId=1c4e13e3497b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c4e13e3497b, replyNumber=0, likeNumber=16, createdTime=2018-08-22, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c4e13e3497b, moduleTitle=华氏巨球蛋白血症/淋巴浆细胞淋巴瘤 NCCN 新版指南（2018.V1）解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c4e13e3497b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702495, encodeId=e3d91e024950c, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率, objectType=article, longId=141010, objectId=cb7914101089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb7914101089, replyNumber=0, likeNumber=74, createdTime=2018-10-11, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb7914101089, moduleTitle=Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb7914101089)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702513, encodeId=91831e025134c, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：套细胞淋巴瘤, objectType=article, longId=147977, objectId=9a3714e97792, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a3714e97792, replyNumber=0, likeNumber=100, createdTime=2019-05-21, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a3714e97792, moduleTitle=Blood：套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a3714e97792)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702473, encodeId=10e51e0247397, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V2）, objectType=article, longId=133262, objectId=6aec1332625b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aec1332625b, replyNumber=0, likeNumber=18, createdTime=2018-06-30, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aec1332625b, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aec1332625b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702466, encodeId=78051e02466c3, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病／小淋巴细胞淋巴瘤（2018.V3）, objectType=article, longId=130270, objectId=905a1302e0f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=905a1302e0f7, replyNumber=0, likeNumber=18, createdTime=2018-07-03, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=905a1302e0f7, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病／小淋巴细胞淋巴瘤（2018.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=905a1302e0f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702485, encodeId=28091e0248547, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：肿瘤抑制因子——前列腺凋亡反应蛋白4（Par-4），在慢性B细胞淋巴瘤中竟是促进细胞增殖！, objectType=article, longId=136694, objectId=c84213669400, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c84213669400, replyNumber=0, likeNumber=56, createdTime=2018-07-16, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c84213669400, moduleTitle=Blood：肿瘤抑制因子——前列腺凋亡反应蛋白4（Par-4），在慢性B细胞淋巴瘤中竟是促进细胞增殖！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c84213669400)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702475, encodeId=af441e0247564, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V4）, objectType=article, longId=133577, objectId=a18a1335e7e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a18a1335e7e7, replyNumber=0, likeNumber=16, createdTime=2018-10-26, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a18a1335e7e7, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V4）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a18a1335e7e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702453, encodeId=540f1e02453cc, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=范磊教授：结外NK/T细胞淋巴瘤基础与治疗新近进展概览, objectType=article, longId=123147, objectId=68f812314e6b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68f812314e6b, replyNumber=0, likeNumber=81, createdTime=2018-10-14, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68f812314e6b, moduleTitle=范磊教授：结外NK/T细胞淋巴瘤基础与治疗新近进展概览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68f812314e6b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702516, encodeId=17131e02516dc, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：GATA6过表达可诱导CD137配体异常表达，进而促进皮肤T细胞淋巴瘤进展, objectType=article, longId=148521, objectId=7ce6148521ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ce6148521ff, replyNumber=0, likeNumber=61, createdTime=2019-07-24, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ce6148521ff, moduleTitle=Blood：GATA6过表达可诱导CD137配体异常表达，进而促进皮肤T细胞淋巴瘤进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ce6148521ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702443, encodeId=e1b01e02443aa, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：T细胞淋巴瘤（2018.V1）, objectType=article, longId=120432, objectId=e9a6120432d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9a6120432d9, replyNumber=0, likeNumber=20, createdTime=2018-02-04, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9a6120432d9, moduleTitle=NCCN临床实践指南：T细胞淋巴瘤（2018.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9a6120432d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702484, encodeId=fb9d1e0248425, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究, objectType=article, longId=136587, objectId=884f13658e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=884f13658e71, replyNumber=0, likeNumber=66, createdTime=2019-01-29, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=884f13658e71, moduleTitle=Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=884f13658e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702512, encodeId=edd41e02512f7, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=CLIN CANCER RES：克服侵袭性B细胞淋巴瘤Venetoclax耐药策略, objectType=article, longId=147811, objectId=c09f14e81109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c09f14e81109, replyNumber=0, likeNumber=60, createdTime=2018-09-03, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c09f14e81109, moduleTitle=CLIN CANCER RES：克服侵袭性B细胞淋巴瘤Venetoclax耐药策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c09f14e81109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702477, encodeId=72cd1e0247760, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=粘着斑激酶抑制剂克服了骨髓微环境中套细胞淋巴瘤对伊布替尼的耐药性, objectType=article, longId=133938, objectId=84b21339380a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84b21339380a, replyNumber=0, likeNumber=84, createdTime=2018-09-09, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84b21339380a, moduleTitle=粘着斑激酶抑制剂克服了骨髓微环境中套细胞淋巴瘤对伊布替尼的耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84b21339380a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702468, encodeId=182a1e024683d, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Haematologica：剂量调整的EPOCH化疗能改善外周T细胞淋巴瘤患者结局？, objectType=article, longId=130749, objectId=b8ba130e490e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8ba130e490e, replyNumber=0, likeNumber=47, createdTime=2018-10-07, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8ba130e490e, moduleTitle=Haematologica：剂量调整的EPOCH化疗能改善外周T细胞淋巴瘤患者结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8ba130e490e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702506, encodeId=37ca1e0250631, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：DUSP22重组型间变性大细胞淋巴瘤！, objectType=article, longId=146573, objectId=bae61465e394, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bae61465e394, replyNumber=0, likeNumber=60, createdTime=2018-08-27, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bae61465e394, moduleTitle=Blood：DUSP22重组型间变性大细胞淋巴瘤！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bae61465e394)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702465, encodeId=4ec81e02465a6, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用, objectType=article, longId=129689, objectId=eb3012968908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb3012968908, replyNumber=0, likeNumber=18, createdTime=2018-10-14, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb3012968908, moduleTitle=2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb3012968908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702440, encodeId=854c1e02440d3, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=FDA加速批准acalabrutinib用于治疗套细胞淋巴瘤, objectType=article, longId=118531, objectId=b43711853163, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b43711853163, replyNumber=0, likeNumber=77, createdTime=2018-06-10, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b43711853163, moduleTitle=FDA加速批准acalabrutinib用于治疗套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b43711853163)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702494, encodeId=a57e1e02494d8, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V4）, objectType=article, longId=138795, objectId=e0e8138e95cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0e8138e95cb, replyNumber=0, likeNumber=20, createdTime=2018-07-28, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0e8138e95cb, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V4）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0e8138e95cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702472, encodeId=730c1e0247249, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：乙肝病毒感染可增加B细胞淋巴瘤患病风险，并可恶化其预后, objectType=article, longId=132937, objectId=93bd13293e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93bd13293e2c, replyNumber=0, likeNumber=56, createdTime=2018-05-20, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93bd13293e2c, moduleTitle=Blood：乙肝病毒感染可增加B细胞淋巴瘤患病风险，并可恶化其预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93bd13293e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702445, encodeId=2f9d1e02445c5, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=【ASH 2017】一线免疫化疗后序贯利妥昔单抗维持治疗套细胞淋巴瘤的长期随访结果, objectType=article, longId=120688, objectId=a371120688d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a371120688d3, replyNumber=0, likeNumber=73, createdTime=2018-07-19, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a371120688d3, moduleTitle=【ASH 2017】一线免疫化疗后序贯利妥昔单抗维持治疗套细胞淋巴瘤的长期随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a371120688d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞淋巴瘤

2020-05-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

华氏巨球蛋白血症/淋巴浆细胞淋巴瘤 NCCN 新版指南（2018.V1）解读

2018-08-22

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率

2018-10-11

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：套细胞淋巴瘤

2019-05-21

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：B细胞淋巴瘤（2018.V2）

2018-06-30

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：慢性淋巴细胞白血病／小淋巴细胞淋巴瘤（2018.V3）

2018-07-03

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：肿瘤抑制因子——前列腺凋亡反应蛋白4（Par-4），在慢性B细胞淋巴瘤中竟是促进细胞增殖！

2018-07-16

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V4）

2018-10-26

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

范磊教授：结外NK/T细胞淋巴瘤基础与治疗新近进展概览

2018-10-14

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：GATA6过表达可诱导CD137配体异常表达，进而促进皮肤T细胞淋巴瘤进展

2019-07-24

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：T细胞淋巴瘤（2018.V1）

2018-02-04

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：PI3Kδ抑制剂（INCB040093）单独或联合JAK1抑制剂（itacitinib）用于复发性/难治性B细胞淋巴瘤的安全性和疗效研究

2019-01-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

CLIN CANCER RES：克服侵袭性B细胞淋巴瘤Venetoclax耐药策略

2018-09-03

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

粘着斑激酶抑制剂克服了骨髓微环境中套细胞淋巴瘤对伊布替尼的耐药性

2018-09-09

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Haematologica：剂量调整的EPOCH化疗能改善外周T细胞淋巴瘤患者结局？

2018-10-07

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：DUSP22重组型间变性大细胞淋巴瘤！

2018-08-27

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用

2018-10-14

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

FDA加速批准acalabrutinib用于治疗套细胞淋巴瘤

2018-06-10

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：B细胞淋巴瘤（2018.V4）

2018-07-28

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：乙肝病毒感染可增加B细胞淋巴瘤患病风险，并可恶化其预后

2018-05-20

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

【ASH 2017】一线免疫化疗后序贯利妥昔单抗维持治疗套细胞淋巴瘤的长期随访结果

2018-07-19

科室
- - 订阅+
  - 更多科室
工具
服务